Business Context and Reporting Period
Nanoviricides, Inc. filed a Form 8-K on June 19, 2014, reporting a material modification to the rights of security holders. The company is incorporated in Nevada and maintains its principal executive offices in West Haven, Connecticut.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on a corporate action regarding warrant terms.
Material Changes
Effective June 19, 2014, the company amended the terms of warrants to purchase an aggregate of 3,079,078 shares of common stock. The primary change was extending the expiration date of all warrants from June 30, 2014, to August 15, 2014. No other terms, including the exercise price of $3.50 per share, were amended.
- Total Warrants Affected: 3,079,078 shares
- Original Expiration: June 30, 2014
- New Expiration: August 15, 2014
- Exercise Price: $3.50 per share (unchanged)
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific modification of warrant terms.
Investor Verification Checklist
- Verify the current market price of Nanoviricides common stock relative to the $3.50 warrant exercise price to assess the likelihood of exercise.
- Confirm the total number of outstanding shares and the potential dilution impact if all 3,079,078 warrants are exercised by the new August 15, 2014 deadline.
- Review the company's cash position to determine if it has sufficient liquidity to fund operations until the new warrant expiration date.